@AndersonJames34
Joined January 2015
  • Tweets140
  • Following248
  • Followers68
Antibiotic development “is a specialist field, and it takes a long time for people to build up that expertise. So again, there is an urgency to try and stop that brain drain before it's lost further.” Insightful @CIDRAP Q&A w/@AndersonJames34 cidrap.umn.edu/antimicrobial… #AMR

Industry group pushes for more progress against antimicrobial resistance

cidrap.umn.edu
3
8
1,289
Fewer than 30 #antibiotics currently in development target #drugresistant bacteria identified by the @WHO as the highest priority. More in @sciam: buff.ly/401UctB
5
5
376
"This is an area of true need. There has not been a new #antibiotic approved for the treatment of S. aureus bacteremia for over 15 years," @DukeMedSchool’s Thomas Holland, MD, says. cidrap.umn.edu/antimicrobial…

Antibiotic shows efficacy against complicated Staph bacteremia

cidrap.umn.edu
10
15
1,648
This week, I am in New York for the United Nations General Assembly Week 🗽 With three High-Level Meetings on global health and half time for realising the Sustainable Development Goals, we now need to galvanise and look ahead to next year’s meeting on AMR 💊
21
58
3,787
James Anderson retweeted
IFPMA@IFPMA6 Sep 2023
New @IPPSecretariat comment published by @TheLancet on delivering the #100DaysMission. It’s critical that we learn the right lessons from the #COVID19 response to better prepare for future pandemics. Read @IFPMA’s priorities here: ifpma.org/insights/five-prio… – at Geneva, Switzerland

Five priorities for future pandemic preparedness and response | IFPMA

As the global architecture for pandemic preparedness and response is discussed, IFPMA shares practical solutions and recommends focusing on five priorities.

ifpma.org
International Pandemic Preparedness Secretariat@IPPSecretariat6 Sep 2023
“The global community should use lessons from the COVID-19 pandemic as a mandate for improved pandemic preparedness” #100DaysMission Science & Technology Expert Group & IPPS Deputy Head @charlie_baker23 in a new opinion piece for @TheLancet 🧪💊💉 thelancet.com/journals/lance…
2
6
537
James Anderson retweeted
IFPMA@IFPMA8 Aug 2023
#Cancer and #AMR are interlinked, as cancer patients' weakened immune systems leave them unprepared to fight off superbugs. Incentives for #antibiotics R&D can help us address these "twin epidemics."⤵️bit.ly/45dB7WB
3
6
504
“As more drug-resistant diseases, such as #gonorrhea, staphylococcus infections and strains of tuberculosis become increasingly persistent, time is not on our side.” –@innovativemeds @pcfralick windsorstar.com/opinion/lett…

Guest column: Canada must properly fund plan to fight antimicrobial resistance

By Pamela FralickThe Pan-Canadian Action Plan on Antimicrobial Resistance (AMR) announced by the federal government last month is an important first step

windsorstar.com
7
11
850
James Anderson retweeted
IFPMA@IFPMA13 Aug 2023
Progress in #globalhealth means people can live longer and healthier lives. Our collaborations help drive different activities in low- and middle-income countries that contribute toward #UHC and #HealthforAll🌎. Explore them on globalhealthprogress.org/
1
3
285
Thanks to @CSEINDIA for organising a great discussion and for the invitation to take part! We need to collaborate, co-operate and innovate to solve the antibiotic development and access crisis. #AMR #stopsuperbugs #antibiotics #antibacterials #pushfunding #pullincentives
Rajeshwari Sinha@rajeshwari_s1430 Jul 2023
Replying to @CSEINDIA
@CSEINDIA sounds dire warning on dipping #antibiotics #research. Our full package ⬇️ Press release🔗: rb.gy/xan3h Webinar on abx R&D crisis🔗:rb.gy/1hnmp @down2earthindia story🔗: rb.gy/7gq9e #AntimicrobialResistance #antibioticresistance #AMR

Very few new antibiotics being developed, even as antibiotic resistance grows – this is signalling...

@down2earthindia

cseindia.org
5
6
559
James Anderson retweeted
Jeremy Knox@_Jeremy_Knox30 May 2023
What could the next two decades of change look like in the infectious disease R&D ecosystem? New discussion paper from the @wellcometrust policy team sets out a vision for ambitious transformation - to help ensure we have the tools 💉💊🔬 we need to face 📈 infections 👇 (1/3)
Wellcome
@wellcometrust30 May 2023
Infectious diseases account for a quarter of all global deaths. We need better vaccines, tests and drugs to reduce this burden. But the global research and development (R&D) system isn’t delivering them. That’s why we’re calling for reform ⤵️ wellcome.org/reports/towards…

Towards a reformed research and development ecosystem for infectious disease | Reports | Wellcome

This paper outlines problems that exist within the infectious disease research and development (R&D) ecosystem with potential solutions and routes for change.

wellcome.org
1
9
1
23
8,141
James Anderson retweeted
IFPMA@IFPMA16 May 2023
📢 Mark your calendars! On the sidelines of the #WHA76 (21-30 May, Geneva), IFPMA is organizing a series of events on #UHC, clinical trials, and #digitalhealth. Information are updated regularly on our website, check it out!👇 ifpma.org/events/

6
2
11
1,243
“If we don’t get some policy changes and develop the right financial incentives to reward risk taking,” CEO Henry Skinner said, “then the little innovation we have will, I think, dry up nearly completely.” #AMR ft.com/content/2730bf0a-91e6…

Impact funds help fight dementia and antibiotic resistance

Some of the world’s biggest health challenges do not lend themselves to conventional investment

ft.com
4
11
866
Policymakers must act now on #AMR “because, without timely interventions, investors will continue putting their money into other therapeutic areas; antibiotic companies will go bankrupt; and patients will continue suffering,” writes @JohnAlterIII globalcause.co.uk/infectious…

Why we won't be able to 'warp speed' our way through antibiotics

Smart policies that encourage innovation and investment could give us a fighting chance against superbugs.

globalcause.co.uk
6
1
12
926
“No other class of drugs has served humanity’s collective interests like antibiotics have. Yet, they remain dangerously undervalued in today’s marketplace,” writes @HeideckerMartin #AMR healtheuropa.com/catalysing-… via @HealthEuropa

Catalysing a New Golden Age of Antimicrobials

Martin Heidecker, CIO of AMR Action Fund outlines the need for a sustainable ecosystem of research and development for antimicrobials.

healtheuropa.com
1
12
18
2,389
James Anderson retweeted
IFPMA@IFPMA16 Mar 2023
Science & innovation delivered medical countermeasures to fight against #COVID19 in record time, but discussions on weakening IP protections risk hindering the #innovation system that enabled this in the first place. @ThomasCueni in @swissinfo_en⬇️ bit.ly/3YwSheg

Covid-19 innovations needed today and for future pandemics

The World Trade Organization ongoing discussions on watering down intellectual property protections need to look more closely at the facts.

swissinfo.ch
5
1
8
1,397
Pleased to take part in this important meeting and share the progress made by the private sector as well as the asks we have to governments globally
Chris Fearne
@chrisfearne6 Feb 2023
Honoured to chair this week the 6th Meeting of the Global Leaders Group @GLGAMR on Antimicrobial Resistance @WHO @WOAH @FAO @UNEP
1
4
188
January is #OneHealthAwarenessMonth. Why does #OneHealth matter? Find out in our #infographic. Learn about OHT's future headquarters for One Health research, education, and action in our podcast with OHT's Ramanan Laxminarayan. Listen here: onehealthtrust.org/news-medi…
19
2
27
2,545
James Anderson retweeted
IFPMA@IFPMA8 Jan 2023
We are pleased to see new international investments by the industry backed @AMRActionFund toward accelerating antibiotic R&D to #beatAMR. Now, global policymakers must also step up & take action toward the development of new #antibiotics. More in @axios ⬇️
Axios
@axios6 Jan 2023
Everyone agrees that the world needs new antibiotics, as the number of drug-resistant infections continues to soar. But there's little agreement on how to finance their development. trib.al/vznUd4d
1
2
413
We are thrilled to announce our investment into @BioVersys! The antibiotics they are developing target some of the highest-priority drug-resistant pathogens and could deliver significant benefits to patients suffering from life-threatening infections. amractionfund.com/blog-2022/… #AMR
1
11
7
34
17,762
👏 Include vaccines in the fight against drug-resistant #superbugs. 👏 Let's say it louder for the folks in the back. Learn why in our OWOH #podcast with Dr. David Heymann of @LSHTM_AMR @LSHTM Listen here: onehealthtrust.org/news-medi… #fightamr #amr
22
4
35
7,140
Load more